Oral Abstract Session
Exciting Developments in CKD Research: From Diagnostics to Management and More
October 23, 2026 | 04:30 PM - 06:00 PM
Location: Mile High Ballroom 1D, Convention Center
Session Description
Oral Abstract Session
Learning Pathway(s)
- CKD Non-Dialysis
Moderators
Presentations
Tirzepatide Reduces Rapid Kidney Function Decline in Patients with Type 2 Diabetes, CKD Stage 3, and Elevated Apoptotic Proteins
Urinary Metabolomic Age Acceleration Predicts Mortality in Patients with CKD: The CRIC Study
Urinary Fetuin-A Predicts Kidney Outcomes and Identifies Residual Risk Across Treatment Arms in the CREDENCE Trial
CKD-Specific Probiotic Strain KT-301 Significantly Slows Progression in Stage 4 CKD: Results of a Randomized, Double-Blind, Phase 2b Study
Plasma Proteomic-Derived Signature of the Histopathologic Chronicity Score and the Risk of Kidney Failure
Comprehensive Identification of Therapeutic Targets in CKD: Integrating Population Genetics with High-Throughput Clustered Regularly Interspaced Short Palindromic Repeats Interference (CRISPRi) Perturb-seq
Diagnostic Inertia in CKD: Delayed Recognition of Abnormal Kidney Biomarkers in a Large Real-World Electronic Health Record Cohort
Rilparencel Is Associated with a Graft-Adjacent Remodeling Response and Preserved Vascular Integrity in an Immunocompromised Rat CKD Model
MRI Kidney Parenchymal Volume Identifies a Hidden CKD-Risk Phenotype in Adults with Normal eGFR: UK Biobank Analysis of 34,646 Adults